Antipsychotic reduction goal attainable, medical expert says

Share this article:

Providers still have two months left to achieve a reduction of 15% in off-label use of antipsychotics, a goal that is achievable, a top medical expert says.

The Centers for Medicare & Medicaid Services, with the support of the American Health Care Association and LeadingAge, set the goal in the wake of several reports about alleged overuse of the medications among nursing home residents.

For a nursing home with 100 residents with 22 on antipsychotics, stopping three or four residents achieves the 15% reduction, pointed out Cheryl Phillips, M.D., Senior Vice President for Advocacy and Public Policy at LeadingAge, in an interview with McKnight's Editor James M. Berklan. 

“Yes, it is a little scary, but I am optimistic that the 15% reduction will happen,” Phillips said. “But I'm also optimistic because it's changing the framework just from meds to focusing on this to, ‘How do I do this and do a better job of taking care of those with dementia?'”

Phillips also discussed the most recent bill from Sen. Herb Kohl (D-WI) that tackles, among other topics, informed consent of antipsychotics use.

“It is always interesting when Congress practices medicine,” Phillips said wryly. “We are of the position that we believe very much in information sharing. My concern is that we don't devolve into just a consent form, a paper-signing process. That will in essence bring us further away from true, engaged decision-making. 

The video interview, conducted during the LeadingAge 2012 national convention in Denver on Oct. 23, can be seen above or at www.mcknights.com. Click here to read the transcript.

Share this article:

More in News

Skilled nursing facilities with poor quality ratings do not readmit more patients to hospitals, researchers find

Skilled nursing facilities with poor quality ratings do ...

Low-quality and high-quality skilled nursing facilities readmit about the same proportion of residents to hospitals, suggest research findings recently published in the American Journal of Medical Quality.

Cipro and related antibiotics increase MRSA risk in long-term care facilities, study ...

Long-term care residents on a fluoroquinolone antibiotic such as Cipro are at an increased risk for methicillin-resistant Staphylococcus aureus, researchers in France have found.

Jonathan Blum, who oversaw long-term care reforms, resigns as head of Medicare

The nation's top Medicare official, Jonathan Blum, is leaving his post next month, news outlets reported Tuesday. Blum became a familiar figure to long-term care providers through Open Door Forum calls and other outreach efforts during his five-year tenure, as he guided implementation of Medicare ...